Clinical trial
Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced…
NCT00038701 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00038701 |
|---|---|
| Title | Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas |
| Official title | Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients With Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Neoplasms |
| Intervention type | Drug |
| Interventions | TNP-470 |
| Enrollment | 6 |
| Start date | Aug 1, 1999 |
| Primary completion | May 11, 2004 |
| Completion | May 11, 2004 |
| First posted | Jun 5, 2002 |
| Last update posted | Nov 1, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: